These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21819005)

  • 41. Thyroid gland function and autoimmunity in children with alopecia universalis.
    Bruno OD; Allevato MA; Contreras LN; Khoury E; Bosco S; Donatti L
    Medicina (B Aires); 1985; 45(1):25-8. PubMed ID: 3880104
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of endocrine ophthalmopathy].
    Raith L
    Z Allgemeinmed; 1973 Dec; 49(35):1727-30. PubMed ID: 4131142
    [No Abstract]   [Full Text] [Related]  

  • 43. [Titers of antibodies against thyroid membrane antigens in patients with Graves-Basedow disease and progressive infiltrative ophthalmopathy during treatment with glucocorticoids and retro-orbital tissue irradiation].
    Pilarska K; Syrenicz A; Czekalski S; GoĊ‚ebiowska I; Andrzejewska W; Krzystolik Z
    Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):824-6. PubMed ID: 1669170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of retrobulbar volume change with resected orbital fat volume and proptosis reduction after fatty decompression for Graves ophthalmopathy.
    Liao SL; Huang SW
    Am J Ophthalmol; 2011 Mar; 151(3):465-9.e1. PubMed ID: 21232731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Choice the appropriate therapy according to the clinical features of the thyroid associated ophthalmopathy].
    Xiao LH
    Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1060-2. PubMed ID: 17415960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.
    Pedro AB; Romaldini JH; Takei K
    Neuroimmunomodulation; 2011; 18(1):45-51. PubMed ID: 20628263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re: "Sinus opacification associated with exacerbation of thyroid eye disease".
    Wiwanitkit V
    Ophthalmic Plast Reconstr Surg; 2011; 27(1):65. PubMed ID: 21268305
    [No Abstract]   [Full Text] [Related]  

  • 48. Management of Graves' ophthalmopathy.
    Wiersinga WM
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracranial hemorrhage complicating an orbital decompression.
    Badilla J; Dolman PJ
    Orbit; 2008; 27(2):143-5. PubMed ID: 18415878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of subgroups of euthyroid graves's ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith FJ
    N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Borderline thyroid function tests: so easy to look at, so hard to define.
    Khatami Z; Handley G; Brandon H; Weaver J
    Ann Clin Biochem; 2006 Jan; 43(Pt 1):77-9. PubMed ID: 16390614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid eye disease.
    Hsu HJ; Hsu CK; Chen TS; Hsu CH
    QJM; 2016 Jan; 109(1):67-8. PubMed ID: 26450988
    [No Abstract]   [Full Text] [Related]  

  • 53. VISA Classification for Graves orbitopathy.
    Dolman PJ; Rootman J
    Ophthalmic Plast Reconstr Surg; 2006; 22(5):319-24. PubMed ID: 16985411
    [No Abstract]   [Full Text] [Related]  

  • 54. Endocrine exophthalmos or orbital pseudotumour.
    Feek CM; Donaldson AA; Toft AD
    Lancet; 1981 Jan; 1(8213):217-8. PubMed ID: 6109880
    [No Abstract]   [Full Text] [Related]  

  • 55. Resolution of Pseudoptosis after Anti-inflammatory Treatment of the Contralateral Eye in Thyroid-associated Ophthalmopathy.
    Xu DD; Zhang ZH; Xu HY; Li H; Liu YH
    Chin Med J (Engl); 2016 Jun; 129(12):1503-4. PubMed ID: 27270551
    [No Abstract]   [Full Text] [Related]  

  • 56. Beyond a typical thyroid eye disease.
    Kashkouli MB
    Middle East Afr J Ophthalmol; 2013; 20(3):185-6. PubMed ID: 24014977
    [No Abstract]   [Full Text] [Related]  

  • 57. A Review of Imaging Modalities in Thyroid-associated Orbitopathy.
    North VS; Freitag SK
    Int Ophthalmol Clin; 2019; 59(4):81-93. PubMed ID: 31569136
    [No Abstract]   [Full Text] [Related]  

  • 58. Fourth International Thyroid Eye Disease Symposium: Introduction.
    Uddin JM
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S1-S2. PubMed ID: 29985834
    [No Abstract]   [Full Text] [Related]  

  • 59. Thyroid Eye Disease and Myasthenia Gravis.
    Bojikian KD; Francis CE
    Int Ophthalmol Clin; 2019; 59(3):113-124. PubMed ID: 31233419
    [No Abstract]   [Full Text] [Related]  

  • 60. Painful Diplopia: Do Not Forget Thyroid-Associated Ophthalmopathy.
    Mavridis T; Velonakis G; Zouvelou V
    Am J Med; 2021 Apr; 134(4):e239-e240. PubMed ID: 32931761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.